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Question: After stroke, does treadmill training provide greater beneﬁt to the subgroup of community-
dwelling people who walk faster than 0.4 m/s than those who walk more slowly? Design: Subgroup
analysis of a randomised trial: the AMBULATE trial. Participants: 68 people with stroke living in the
community. Intervention: The experimental group received 30 minutes of treadmill and overground
walking, three times a week for four months; the control group received no intervention. Outcome
measures: The primary outcome was walking distance covered during the six-minute walk test. Other
outcomes were comfortable and fast walking speed and health status. Results: At four months, in the
subgroup of participants with a baseline comfortable walking speed of > 0.4 m/s, treadmill training
produced an extra distance of 72 m (95% CI 23 to 121) and an increased comfortable speed of 0.16 m/s
(95% CI 0.00 to 0.32), compared with the subgroup with a speed of  0.4 m/s. There was also a trend
towards an extra fast speed of 0.17 m/s (95% CI –0.04 to 0.36). There was no extra effect of treadmill
training in the faster walkers in terms of EuroQol 5Q-5D. There were no differences between the
experimental and control groups between subgroups in the long term. Conclusion: Treadmill training is
more likely to beneﬁt people who walk at a speed of > 0.4 m/s. Clinicians should use comfortable
walking speed to predict the potential for improvement and to guide intervention. Trial registration:
ACTRN12607000227493. [Dean CM, Ada L, Lindley RI, (2014) Treadmill training provides greater
beneﬁt to the subgroup of community- dwelling people after stroke whowalk faster than 0.4m/s: a
randomised trial. Journal of Physiotherapy 60: 97–101]
 2014 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Losing the ability to walk independently is one of the most
disabling consequences of stroke.1 Despite some stroke survivors
regaining the ability towalk, their walking speed and distancemay
remain signiﬁcantly reduced. Treadmill training is increasingly
being used as a method for increasing walking speed and distance
in stroke survivors, both for ambulatory2 and non-ambulatory3
individuals. Treadmill training has been shown to be effective at
improving walking speed and distance in ambulatory stroke
survivors, although meta-analysis shows that the size of the effect
is moderate, with an improvement of 40 m in six-minute walking
distance and 0.12 to 0.14 m/s in walking speed.2 These moderate
improvements may be due in part to the heterogeneous nature of
stroke, which has the potential to dilute the effect of intervention.
Although randomised trials assume an equal effect of the
intervention for all participants in the sample, the effect of
intervention for stroke survivorsmaydiffer, dependingon individualhttp://dx.doi.org/10.1016/j.jphys.2014.03.004
1836-9553/ 2014 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/3.0/).characteristics. For example, people with acute4 or chronic5 stroke
with poor levels of ambulation appear to have an increased risk
of falling following exercise interventions, compared with those
with higher levels of ambulation. Moreover, the study of people
with chronic stroke by Dean and colleagues5 found a greater effect
of intervention on walking speed and distance for those able to
walk faster than 0.8 m/s at baseline. The heterogeneous nature
of stroke presentation and recovery makes it difﬁcult to establish
guidelines for rehabilitation and to predict who is likely to improve
as a result of intervention. Establishing relevant subgroups of
stroke survivors may allow therapists to determine which individu-
als are likely to beneﬁt most from a speciﬁc intervention.
The AMBULATE trial6 was a randomised trial that investigated
the effect of treadmill walking training in people with chronic
stroke living in the community. This trial showed that participants
who undertook four months of treadmill training improved
signiﬁcantly more than a no-intervention control group on several
outcomes: increased comfortable walking speed by 0.12 m/s,.V. This is an open access article under the CC BY-NC-ND license (http://
Dean et al: Community treadmill walking after stroke98increased fast walking speed by 0.15 m/s and increased walking
distance by 38 m. Although the participants all walked slower than
normal at baseline (< 1.1 m/s), ambulatory levels were heteroge-
neous (mean walking speed 0.50 m/s, SD 0.26). This raises the
possibility that the effect of treadmill training in this group of
ambulatory stroke survivors may differ, based on their baseline
walking speed.
Walking speed has been shown to be associated with
community ambulation and participation following stroke.7,8
There is evidence that people who walk very slowly (ie, gait
speed  0.4 m/s) rarely venture outside their homes, while those
who walk faster (ie, gait speed > 0.4 m/s) have some ability to
ambulate around their community. Thosewhowalk even faster (ie,
gait speed > 0.8 m/s) are able to ambulate fully around their
community.7 As the current study is a secondary analysis of the
AMBULATE trial, investigating whether baseline walking speed in
people with chronic stroke has a differential effect on mobility
outcomes following treadmill training, a cut-off of 0.4 m/s was
used to subdivide participants from the AMBULATE trial into faster
versus slowerwalkers. Therefore, the speciﬁc research question for
this study was:
After stroke, does treadmill training to improve walking speed
anddistancehaveagreater effecton community-dwellingpeople
whowalk faster than 0.4 m/s than those whowalkmore slowly?Method
Design
Data collected in the AMBULATE trial6 were used in this study.
The AMBULATE trial was a three-arm randomised trial with
concealed allocation, assessor blinding, and intention-to-treat
analysis involving 102 people with stroke who could walk slowly,
lived in the community and had ceased all formal rehabilitation. An
experimental group undertook 30 minutes of treadmill and
overground walking thrice per week for four months, a second
experimental group undertook training for two months, while the
control group had no intervention. At four months, the experi-
mental group that had trained for four months walked further,
faster and reported better health than those who received no
training. However, this effect had disappeared by 12 months. The
present study is a subgroup analysis of slow and fast walkers in the
experimental group that trained for fourmonths, and in the control
group. Any differential effects of walking speed on the outcomes
that demonstrated improvement in the primary analysis, ie,
walking distance, walking speed (comfortable and fast) and health
status were examined.
Participants
Participants with stroke were eligible for inclusion if they: were
within ﬁve years of their ﬁrst stroke; were adults capable of
providing consent (deﬁned as having a Mini Mental State Exam
score > 23); had been discharged from formal rehabilitation; were
community dwellers; walked slowly (deﬁned as being able to walk
10 m inmore than 9 seconds across ﬂat ground in bare feetwithout
any aids). Participants were excluded if they had: an unstable
cardiac status precluding them from participation in a treadmill
training program (ie, permission not granted by their medical
practitioner); or had severe cognitive and/or language deﬁcits
(aphasia) precluding them from participation in the training
sessions (ie, unable to follow two-step commands). Participants
were divided into two subgroups according to baseline comfort-
able walking speed (> 0.4 m/s and  0.4 m/s), measured during a
10-m walk test. This cut-off was decided prior to analysis.7Intervention
The experimental group received training based on a previous
treadmill walking program.9 Thirtyminutes of walkingwas carried
out three times a week for 16 weeks. Given that participants could
already walk, treadmill training was conducted without any body-
weight support. It was structured to increase step length, speed,
workload, and automaticity. Overground walking was practised
each session to reinforce the gains achieved during treadmill
training. Overground walking initially comprised 20% of the
intervention time and was progressively increased each week so
that it comprised 50% of the 30-minute intervention time.
Overground walking was deﬁned as a whole-task practice
involving propulsion forwards, backwards, sideways or up and
down stairs. Guidelines were used to outline the progression of
treadmill and overground walking training. The control group
received no intervention.
Outcome measures
The primary outcome was walking, which was quantiﬁed by
measuring the distance walked (in m) during a six-minute walk
test. The instructions for the test were standardised according to
Lipkin and colleagues.10 Participants were instructed to cover as
much ground as possible in six minutes. They were told to walk as
continuously as possible, but they could slow down or stop if
necessary. No encouragement was given, but the investigator
informed participants at the halfway point (three minutes) and
when there was one minute remaining. Participants wore shoes
and used aids if necessary.
Walking was also quantiﬁed by measuring speed (in m/s)
during a 10-m walk test. Participants were timed while walking
independently at their comfortable and fast speeds over themiddle
10-m of a 15-m track (to allow for acceleration and deceleration).
Health status was measured using the EuroQol EQ-5D-3L,
which is a standardised instrument providing a single value for
health status. The EQ-5D-3L records self-rated health on a vertical,
100-mm visual analogue scale where the endpoints are labelled
‘best imaginable health state’ and ‘worst imaginable health state’.
Data analysis
In the main AMBULATE Trial,6 all outcomes were analysed using
an intention-to-treat analysis. Missing data were interpolated from
the nearest measure taken to maintain all outcome measures from
each participant. In the present study, the mean (SD) change of the
outcome measures were calculated at four and 12 months for the
experimental and control groups of the two subgroups (walking
speed  0.4 m/s and > 0.4 m/s). To determine whether treadmill
training to improve walking has more effect on community-
dwelling people after stroke who can walk faster (ie, baseline 10-
mwalk test of> 0.4 m/s), themean difference (95% CI) between the
experimental and control groups between subgroups (walking
speed  0.4 m/s and> 0.4 m/s) for outcomes in the short-term (four
months) and the long-term (12 months) were calculated.11
Results
Flow of participants through the study
Sixty-eight community-dwelling people with stroke partici-
pated in this subgroup analysis. At baseline, all participants
completed the six-minute walk test, a 10-m walk test at
comfortable and fast speed, and the EuroQol 5Q-3L. However,
ﬁve control participants did not complete the 10-m walk test at
Table 1
Baseline characteristics of participants.
Characteristic WS > 0.4m/s
(n=45)
WS  0.4m/s
(n=23)
Exp
(n=23)
Con
(n=22)
Exp
(n=11)
Con
(n=12)
Age (years), mean (SD) 70 (11) 63 (13) 72 (11) 61 (15)
Gender, n males (%) 17 (74) 12 (55) 7 (64) 7 (58)
Side of weakness, n right (%) 12 (52) 9 (41) 6 (55) 4 (33)
Height (m), mean (SD) 1.66 (0.07)
n=22
1.65 (0.09)
n=20
1.63 (0.10) 1.61 (0.08)
n=10
Weight (kg), mean (SD) 80 (14)
n=22
73 (13)
n=20
78 (20) 71 (11)
n=10
BMI (kg/m2), mean (SD) 28.9 (4.5)
n=22
26.6 (3.5)
n=20
28.9 (5.4) 27.6 (4.2)
n=10
Chronicity (months), mean (SD) 22 (17) 17 (12) 23 (16) 24 (14)
Impairments, mean (SD)
Loss of sensation (0 to 2) 0.3 (0.5) 0.4 (0.6) 0.6 (0.7) 0.5 (0.7)
Neglect (0 to 2) 0.18 (0.39) 0.09 (0.29) 0.18 (0.40) 0.17 (0.39)
Spasticity (0 to 4) 0.72 (0.98) 0.78 (0.94)
n=18
0.67 (1.00)
n=9
1.17 (1.27)
Contracture (0 to 2) 0.26 (0.54) 0.59 (0.79) 0.64 (0.81) 0.17 (0.39)
Exp=experimental group, Con= control group, WS=walking speed. For Impairment measures: 0=normal and positive values =greater impairment. Information about
sensory loss was collected using the Nottingham Sensory Assessment, neglect using the Line Bisection Test, and spasticity and contracture using the Tardieu Scale.
Research 99four months, and four control and one experimental participant
did not complete it at 12months. At baseline, 23 participants (34%)
had a walking speed of  0.4 m/s and 45 participants (66%) had a
walking speed of > 0.4 m/s. Table 1 shows the baseline
characteristics of the participants.
Effect of intervention between subgroups
Table 2 presents the six-minute walk test distance, the 10-m
walk test at comfortable and fast speeds, and EuroQol EQ-5D-3L
health status in the short term (four months) and in the long term
(12 months) for both the experimental and control groups of the
two subgroups. In the short term, there were statistically
signiﬁcant differences between the experimental and control
groups between subgroups for the six-minute walk test distance
and for the 10-m walk test comfortable speed. At four months,
treadmill and overground walking training produced an extra
distance of 72 m (95% CI 23 to 121) and an extra comfortable speed
of 0.16 m/s (95% CI 0.00 to 0.32) in the subgroup of participants
with a baseline walking speed of > 0.4 m/s, compared with theTable 2
Mean (SD) for change (gains) in outcomes of experimental and control groups according
difference (95% CI) between groups between subgroups.
Outcome Groups
Subgroup WS>0.4m/s Subgroup WS0.4m/s Su
Exp
(n=23)
Con
(n=22)
Exp
(n=11)
Con
(n=12)
Gains at 4 months
6-min walk test (m) 69 (53) 12 (34) 17 (62) 32 (50)
10-m walk test, comf (m/s) 0.23 (0.23) 0.05 (0.12) 0.08 (0.11) 0.07 (0.10)
10-m walk test, fast (m/s) 0.26 (0.32) 0.06 (0.14) 0.09 (0.09) 0.06 (0.08)
EuroQol 5Q-5D-3L, (0-100) 9 (21) –4 (17) 11 (30) –4 (24)
Gains at 12 months
6-min walk test (m) 13 (106) 8 (37) 28 (79) 7 (67)
10-m walk test, comf (m/s) 0.07 (0.22) 0.06 (0.11) 0.06 (0.24) 0.07 (0.10) 0
10-m walk test, fast (m/s) 0.07 (0.30) 0.06 (0.13) 0.05 (0.26) 0.05 (0.12) 0
EuroQol 5Q-5D, (0-100) 0 (27) 0 (17) 19 (38) –2 (21)
Exp=experimental group, Con= control group, comf= comfortable, WS=walking speedsubgroupwith a baseline speed of 0.4 m/s. Therewas also a trend
towards an extra fast speed of 0.17 m/s (95% CI –0.04 to 0.36).
There was no extra effect of treadmill training in the faster walkers
in terms of EuroQol 5Q-5D-3L. There were no statistically
signiﬁcant differences between the experimental and control
groups between subgroups in the long term for any outcome.
Discussion
This study has shown that patients who walk slowly do worse
on some outcomes at fourmonths and 12months than those with
a moderate-to-fast walking speed. Whilst acknowledging the
general limitations of post hoc secondary analyses, the chance of
spurious ﬁndings was limited by dividing participants into
subgroups based on previous evidence7 prior to analysis.12 At
four months, treadmill and overground walking training for
faster walkers (> 0.4 m/s) had a signiﬁcant additional beneﬁt in
terms of walking distance and speed compared with slower
walkers ( 0.4 m/s). However, the differential effects of theto subgroup, mean difference (95% CI) between groups within subgroups and mean
Difference between groups
within subgroups
Difference between groups
between subgroups
bgroup WS>0.4m/s Subgroup WS0.4m/s Subgroup WS>0.4m/s minus
Subgroup WS0.4m/s
Exp minus Con Exp minus Con Exp minus Con
57 (30 to 84) –15 (–64 to 34) 72 (23 to 121)
0.18 (0.07 to 0.29) 0.01 (–0.08 to 0.10) 0.16 (0.00 to 0.32)
0.20 (0.05 to 0.35) 0.03 (–0.04 to 0.10) 0.17 (–0.04 to 0.38)
13 (1 to 25) 15 (–8 to 38) –2 (–24 to 20)
5 (–43 to 53) 21 (–42 to 84) –16 (–94 to 62)
.01 (–0.10 to 0.12) –0.01 (–0.17 to 0.15) 0.02 (–0.16 to 0.20)
.01 (–0.13 to 0.15) 0.00 (–0.17 to 0.17) 0.01 (–0.21 to 0.23)
0 (–14 to 14) 21 (–5 to 47) –21 (–46 to 5)
.
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time and had disappeared eight months after intervention ceased
(ie, by 12 months). The effect of the training on health status did
not differ between the subgroups at any assessment point.
Therefore, although treadmill and overground walking training is
recommended for people with stroke to improve walking
capacity and speed, the present study’s ﬁndings showed that
the effect of intervention was different depending on initial
walking speed.
In the present trial, a walking speed of 0.4 m/s was used to
separate participants into two subgroups. Those with speeds
 0.4 m/s were considered to be severely impaired slow walkers
and those with speeds above 0.4m/s were considered to be
moderate-to-fast walkers. A cut off of 0.4 m/s meant that the
subgroup of slow walkers included the lowest four categories
(physiological walker, limited household walker, unlimited
household walker and most-limited community walker) and
the moderate-to-faster walkers included the highest two catego-
ries (least-limited community walker and community walker).7
This same cut off was used to deﬁne the slowwalkers in the recent
LEAPS trial.13 The additional beneﬁt of treadmill and overground
walking training related to baseline walking speed declined over
time. Immediately after four months of intervention, the faster
walkers had an additional beneﬁt of 72 m over six minutes
compared with the slower walkers. By 12 months, the additional
beneﬁt had disappeared. The additional beneﬁt in comfortable
and fast-walking speeds for the moderate-to-fast walkers
mirrored the changes in six-minute walking distance. The size
of the additional beneﬁt at 0.16 m/s and0.175 m/s for comfortable
and fast, respectively, indicate that these beneﬁts are clinically
meaningful.14,15
The ﬁnding that there is a differential effect of treadmill and
overground walking training based on baseline comfortable
walking speed is consistent with other intervention trials after
stroke, with slower walkers performing worse compared to faster
walkers. In a community stroke trial of exercise classes and a home
program, larger improvements in walking speed and six-minute
walking distance were found for faster walkers compared with
slower walkers.5
The major clinical implication of this study and others, which
ﬁnd signiﬁcant subgroup intervention effects, is the need to
target intervention. Given the heterogeneity of stroke, the ‘one
size ﬁts all’ approach of clinical trials runs the risk of discounting
worthwhile intervention. The present study’s ﬁndings suggest
that the treadmill and overground walking intervention should
be implemented for those with initial walking speeds of greater
than 0.4 m/s, whereas poor walkers may need additional and/or
different interventions to enhance their community participa-
tion. For more disabled stroke survivors, provision of scooters or
wheelchairs may be a more appropriate intervention to
maximise the opportunity to participate in activities outside
the house.
Maintaining gains after intervention ceases remains the holy
grail of stroke rehabilitation. Clinical trials of community-
dwelling people after stroke repeatedly demonstrate immediate
beneﬁts, which subsequently decrease once intervention ceases.
Future research needs to focus on how stroke survivors with
walking speeds > 0.4 m/s can become life-long exercisers and
maintain a reasonable level of physical activity. The challenge is to
develop appropriate, accessible, low-cost, community exercise
programs that individuals after stroke who have reasonable
walking speed are encouraged to attend on an ongoing basis.
Future research needs to concentrate on implementation and
ways of overcoming the barriers to life-long exercise after stroke
and testing strategies for promoting life-long adherence to
exercise programs.In conclusion, the results of this study demonstrate a
differential effect of a treadmill and overground walking
intervention based on initial walking speed. The additional
beneﬁt of the treadmill and overground walking intervention in
walking distance and speed was greater for those who walked
faster at the start of therapy. However, the additional beneﬁt
declined over time.What is already known on this topic: Despite regaining the
ability to walk, many survivors of stroke do not regain their
original walking speed or distance, which affects participation
in the community. Overall, treadmill training has moderately
beneficial effects on walking speed and distance in stroke
survivors. However, the variability in these outcomes suggests
that different groups of stroke survivors may differ in their
response to treadmill training.
What this study adds: Treadmill training typically provides
greater benefits in walking speed and distance in stroke
survivors whose comfortable walking speed before training
is over 0.4 m/s. Clinicians should use comfortable walking
speed to predict the potential for improvement with treadmill
training.Ethics approval: Sydney University Human Research Ethics
Committee (02–2007/9665) approved this study. All participants
gave informed consent before data collection began.
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